# Diagnostics Sector

Canonical URL: https://biopharmsignal.com/sector/diagnostics

Diagnostics is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Diagnostics, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Diagnostics: 35

## Recent Sector News

- 2026-07-16 12:00 EST — ALNY — [Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/ALNY/alnylam-to-webcast-conference-call-discussing-second-quarter-2026-financial-resu-458d7635) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-16 11:30 EST — VRAX — [Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement](https://biopharmsignal.com/news/VRAX/virax-biolabs-ceo-james-foster-provides-shareholder-update-following-fiscal-2026-e1b97d68) — Source: Virax Biolabs
- 2026-07-15 12:00 EST — ALNY — [Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurologi](https://biopharmsignal.com/news/ALNY/alnylam-highlights-progress-with-neuroscience-programs-at-aaic-2026-showcasing-p-508fc61d) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-14 11:00 EST — BEAT — [HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device](https://biopharmsignal.com/news/BEAT/heartbeam-awarded-new-u-s-patent-expanding-acoustic-sensing-and-fluid-monitoring-e0c78764) — Source: HeartBeam
- 2026-07-13 12:00 EST — TCMD — [Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients](https://biopharmsignal.com/news/TCMD/tactile-medical-enters-exclusive-u-s-distribution-agreement-with-elastimed-for-i-116aea64) — Source: Tactile Systems Technology, Inc.
- 2026-07-10 20:05 EST — VRAX — [Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds](https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-closing-of-exercise-of-preferred-investmen-cc034f76) — Source: Virax Biolabs
- 2026-07-10 13:24 EST — DGX — [One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns](https://biopharmsignal.com/news/DGX/one-in-five-american-workers-tested-had-a-positive-hair-drug-test-in-2025-signal-cb4ae34e) — Source: Quest Diagnostics
- 2026-07-09 18:25 EST — ALNY — [Alnylam to Webcast Presentations at Upcoming Investor Conferences](https://biopharmsignal.com/news/ALNY/alnylam-to-webcast-presentations-at-upcoming-investor-conferences-50fb6676) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-09 18:25 EST — ALNY — [New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutris](https://biopharmsignal.com/news/ALNY/new-data-analyses-presented-at-heart-failure-2026-demonstrate-robust-and-consist-d10768e9) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-09 18:24 EST — ALNY — [Alnylam Issues 2025 Corporate Responsibility Report](https://biopharmsignal.com/news/ALNY/alnylam-issues-2025-corporate-responsibility-report-62023cfe) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-09 18:24 EST — ALNY — [Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics](https://biopharmsignal.com/news/ALNY/alnylam-and-inceptive-form-strategic-ai-collaboration-to-accelerate-the-discover-3d8b2b06) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-09 18:24 EST — ALNY — [Alnylam to Host Tenth “RNAi Roundtable” Webcast Series](https://biopharmsignal.com/news/ALNY/alnylam-to-host-tenth-rnai-roundtable-webcast-series-3988e623) — Source: Alnylam Pharmaceuticals, Inc.
- 2026-07-09 17:35 EST — VRAX — [Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds](https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-exercise-of-preferred-investment-options-f-60095931) — Source: Virax Biolabs
- 2026-07-09 11:30 EST — VRAX — [Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics](https://biopharmsignal.com/news/VRAX/virax-biolabs-signs-multi-country-commercial-supply-agreement-with-fosun-diagnos-d54171ee) — Source: Virax Biolabs
- 2026-07-08 12:52 EST — DGX — [Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI](https://biopharmsignal.com/news/DGX/quest-diagnostics-now-the-largest-clinical-reference-lab-to-extend-oncology-test-e734c702) — Source: Quest Diagnostics
- 2026-07-06 12:00 EST — LCTX — [Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit](https://biopharmsignal.com/news/LCTX/lineage-cell-therapeutics-to-present-at-b-riley-securities-2026-mind-muscle-visi-93d042e3) — Source: Lineage Cell Therapeutics
- 2026-07-01 20:05 EST — NBIX — [Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia](https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-initiates-phase-2-study-of-crinecerfont-in-pediatric-pati-8fe2e2b9) — Source: Neurocrine Biosciences
- 2026-06-30 20:25 EST — SRPT — [Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/SRPT/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635--c021b8ab) — Source: Sarepta Therapeutics
- 2026-06-30 12:30 EST — SRPT — [Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®](https://biopharmsignal.com/news/SRPT/sarepta-announces-fda-acceptance-of-sndas-for-amondys-45-and-vyondys-53-40aea7f9) — Source: Sarepta Therapeutics
- 2026-06-30 11:00 EST — BEAT — [HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule](https://biopharmsignal.com/news/BEAT/heartbeam-completes-enrollment-in-heart-attack-detection-pilot-study-ahead-of-sc-c3aedd75) — Source: HeartBeam

## Companies

- [TXG](https://biopharmsignal.com/company/TXG) — 10x Genomics
- [AXDX](https://biopharmsignal.com/company/AXDX) — Accelerate Diagnostics
- [ALNY](https://biopharmsignal.com/company/ALNY) — Alnylam Pharmaceuticals, Inc.
- [BRLI](https://biopharmsignal.com/company/BRLI) — Bio-Reference Laboratories
- [BNGO](https://biopharmsignal.com/company/BNGO) — BioNano Genomics
- [BJDX](https://biopharmsignal.com/company/BJDX) — Bluejay Diagnostics
- [BCLI](https://biopharmsignal.com/company/BCLI) — Brainstorm Cell Therapeutics Inc.
- [RNAC](https://biopharmsignal.com/company/RNAC) — Cartesian Therapeutics
- [RDY](https://biopharmsignal.com/company/RDY) — Dr. Reddy's Laboratories Ltd
- [LLY](https://biopharmsignal.com/company/LLY) — Eli Lilly
- [EXEL](https://biopharmsignal.com/company/EXEL) — Exelixis
- [EYEN](https://biopharmsignal.com/company/EYEN) — Eyenovia
- [EYPT](https://biopharmsignal.com/company/EYPT) — EyePoint Pharmaceuticals
- [GOVX](https://biopharmsignal.com/company/GOVX) — GeoVax Labs
- [BEAT](https://biopharmsignal.com/company/BEAT) — HeartBeam
- [HSCS](https://biopharmsignal.com/company/HSCS) — HeartSciences
- [HTGM](https://biopharmsignal.com/company/HTGM) — HTG Molecular Diagnostics
- [TIL](https://biopharmsignal.com/company/TIL) — Instil Bio
- [IOVA](https://biopharmsignal.com/company/IOVA) — Iovance Biotherapeutics, Inc.
- [LABP](https://biopharmsignal.com/company/LABP) — Landos Biopharma
- [LCTX](https://biopharmsignal.com/company/LCTX) — Lineage Cell Therapeutics
- [LUCD](https://biopharmsignal.com/company/LUCD) — Lucid Diagnostics
- [EYE](https://biopharmsignal.com/company/EYE) — National Vision
- [NAUT](https://biopharmsignal.com/company/NAUT) — Nautilus Biotechnology
- [NBIX](https://biopharmsignal.com/company/NBIX) — Neurocrine Biosciences
- [PRPO](https://biopharmsignal.com/company/PRPO) — Precipio Diagnostics
- [PRPH](https://biopharmsignal.com/company/PRPH) — ProPhase Labs
- [DGX](https://biopharmsignal.com/company/DGX) — Quest Diagnostics
- [SRPT](https://biopharmsignal.com/company/SRPT) — Sarepta Therapeutics
- [STTK](https://biopharmsignal.com/company/STTK) — Shattuck Labs
- [OMIC](https://biopharmsignal.com/company/OMIC) — Singular Genomics
- [TCMD](https://biopharmsignal.com/company/TCMD) — Tactile Systems Technology, Inc.
- [VRTX](https://biopharmsignal.com/company/VRTX) — Vertex Pharmaceuticals Incorporated
- [VRAX](https://biopharmsignal.com/company/VRAX) — Virax Biolabs
- [ZLAB](https://biopharmsignal.com/company/ZLAB) — Zai Lab Limited